아시아 태평양 항응고제 치료 시장 – 2028년까지의 산업 동향 및 예측

항응고제 치료 시장의 시장 분석 및 통찰력

Data Bridge Market Research는 항응고제 요법이 2021-2028년 예측 기간 동안 약 8.88%의 CAGR을 보일 것이라고 분석했습니다. 표적 요법 모드에 대한 수요 증가, 신약 및 요법 개발을 위한 연구 개발 활동 급증, 부정맥 및 기타 만성 질환의 유병률 증가, 의료 인프라 개발에 대한 지출 증가 는 항응고제 요법 시장 성장에 기여하는 주요 요인입니다.

항응고제 치료는 혈액 응고를 예방하거나 감소시키는 데 사용되는 약물을 사용하는 것입니다. 항응고제 치료는 일반적으로 심근경색, 폐색전증, 뇌졸중 등과 같은 다양한 의학적 상태에서 혈전 위험이 높은 경우에 사용됩니다. 항응고제는 혈소판이 서로 달라붙는 것을 막습니다.

혈관 혈전색전증과  뇌졸중 의 유병률이 증가하는 것과 더불어 노령 인구 기반이 계속 증가하는 것은 시장 성장을 촉진하는 주요 요인입니다. 의료 인프라 개발에 대한 지출 증가, 교통사고 증가, 충족되지 않은 요구 증가, 시장 참여자들 사이에서 새로운 치료법에 대한 수요 급증은 시장 성장을 촉진하는 다른 요인입니다. 새로운 경구 항응고제(NOAC)의 채택 증가는 수익성 있는 시장 성장 기회를 창출할 또 다른 간접적인 결정 요인입니다.

However, unfavourable reimbursement scenario in the developing and under developed economies will pose a major challenge to the market growth. Also, high costs associated with research and development proficiencies will further derail the market growth rate. Inadequate knowledge about pemphigoid in some developing countries, patent expiry from many companies, higher price of NOACs, lack of antidotes for NOACs and availability of alternative therapies will also hamper the market growth rate.

This anticoagulation therapy market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on anticoagulation therapy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Anticoagulation Therapy Market Scope and Market Size

The anticoagulation therapy market is segmented on the basis of treatment, therapeutic class, drug type, route of administration, therapeutic area, procedure, type, end user and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the anticoagulation therapy market is segmented into deep vein thrombosis (DVT), pulmonary embolism (PE), arterial thromboembolism (AT), stroke and others.
• On the basis of therapeutic class, the anticoagulation therapy market is segmented into novel oral anticoagulants (noac), heparin, vitamin k antagonists and others.
• Based on drug type, the anticoagulation therapy market is segmented into bivalirudin, dabigatran, edoxaban, betrixaban, rivaroxaban, apixaban, enoxaparin, delteparin and others.
• On the basis of route of administration, the anticoagulation therapy market is segmented into oral and Injectable.
• Based on therapeutic area, the anticoagulation therapy market is segmented into cardiovascular diseases, oncology, respiratory, nephrology, CNS and others.
• On the basis of procedure, the anticoagulation therapy market is segmented into pre-surgical procedures, post-surgical procedures, kidney dialysis and heart valve replacement.
• On the basis of type, the anticoagulation therapy market is segmented into generics and branded.
• The end user segment of anticoagulation therapy market is segmented into hospitals, clinics, homecare, ambulatory surgical centers and others.
• Based on distribution channel, the anticoagulation therapy market is segmented into hospital pharmacy, retail pharmacy and online pharmacy.

Anticoagulation Therapy Market Country Level Analysis

The anticoagulation therapy market is analysed and market size insights and trends are provided by country, treatment, therapeutic class, drug type, route of administration, therapeutic area, procedure, type, end user and distribution channel as referenced above.

The countries covered in the anticoagulation therapy market report are Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific.

China in Asia-Pacific region dominate the anticoagulation therapy market owing to the prevalence of cardiovascular diseases (CVDs) and arrhythmia, growing adoption of blood thinning medications and ever-rising geriatric population base.

The country section of the anticoagulation therapy market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The anticoagulation therapy market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Anticoagulation Therapy Market Share Analysis

The anticoagulation therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to anticoagulation therapy market.

항응고제 치료 시장 보고서에서 다루는 주요 기업으로는 Hikma Pharmaceuticals PLC, Mylan NV, Teva Pharmaceutical Industries Ltd., Novartis AG, Eisai Co., Ltd., Pfizer Inc., Sanofi, F. Hoffmann-La Roche Ltd, Fresenius Kabi AG, Aspen Holdings, Shanghai Fosun Pharmaceutical(Group)Co., Ltd., Cipla Inc., Johnson & Johnson Services, Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, DAIICHI SANKYO COMPANY, LIMITED, Eagle Pharmaceuticals, Inc., Endo International plc, Mitsubishi Tanabe Pharma Corporation, Portola Pharmaceuticals, Inc., Taro Pharmaceutical Industries Ltd. 등이 있습니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-44722